Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|October 27, 2009
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancerSteven J Cohen, Mark M Zalupski, Manuel R Modiano, et al.
Cancer Medicine|August 13, 2017
INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trialYehuda Z Patt, Waheed Murad, Mohammed H Fekrazad, et al.
American Journal of Clinical Oncology|September 1, 2007
Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial resultsYehuda Z Patt, Fa-Chyi Lee, James E Liebmann, et al.
The Oncologist|November 22, 2017
Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal CancerEmilio P Araujo-Mino, Yehuda Z Patt, Cristina Murray-Krezan, et al.
Cancer|July 27, 2004
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinomaYehuda Z Patt, Manal M Hassan, Alvaro Aguayo, et al.
Cancer|July 4, 2013
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinomaAhmed O Kaseb, Junichi Shindoh, Yehuda Z Patt, et al.
American Journal of Clinical Oncology|August 3, 2005
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancersGhassan K Abou-Alfa, Eric K Rowinsky, Yehuda Z Patt, et al.
Annals of Surgical Oncology|May 8, 2003
Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancerCourtney L Scaife, Steven A Curley, Francesco Izzo, et al.
Journal of Hepatology|December 17, 2008
The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United StatesManal M Hassan, Margret R Spitz, Melanie B Thomas, et al.
Hepatology (Baltimore, Md.)|April 29, 2009
Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United StatesManal M Hassan, Ahmed Kaseb, Donghui Li, et al.
Pageof 3